Find your path to Jill
295 people in our graph share verified history with Jill — schools, employers, funds. One of them is your warm intro.
Yervand SarkisyanunlockedJill: together at University of Pittsburgh (2000–2001)
Jill: together at Takeda
×7Jill: together at University of Pittsburgh
×2Jill: together at RA Capital
About
Jill Wykosky is a Venture Partner at Raven (RA Ventures). She previously spent eleven years at Takeda Pharmaceuticals, where she served as Head of Neurogastroenterology Research and built a biology and pharmacology team within the Gastroenterology Drug Discovery Unit, overseeing preclinical discovery work across sites in San Diego, CA and Cambridge, MA. Her drug discovery experience spans small molecule, peptide, antibody, and cell therapy modalities, and she holds a B.S. in Microbiology from the University of Pittsburgh and a Ph.D. in Molecular Medicine from Wake Forest University School of Medicine, followed by a post-doctoral fellowship at the Ludwig Institute for Cancer Research San Diego Branch.
Experience
- Raven (RA Ventures)Venture Partnercurrent2025 — present
- Nocicera TherapeuticsConsulting CSOcurrent2025 — present
- Nocicera TherapeuticsCo-founder and CSO2024 — 2025
- Solent TherapeuticsConsulting Head of Researchcurrent2021 — present
- Endosome TherapeuticsConsulting CSOcurrent2021 — present
- VisceraCo-founder and CSO2022 — 2025
- TakedaSenior Director, Center for External Innovation2022 — 2024Cambridge, Massachusetts, United States
- TakedaSenior Director, Head of Neurogastroenterology Research2021 — 2023
- TakedaDirector2019 — 2021
- TakedaAssociate Director2016 — 2019San Diego, California, United States
- TakedaSenior Scientist2015 — 2016San Diego, California, United States
- TakedaStaff Scientist2013 — 2015San Diego, California, United States
- Ludwig Institute for Cancer ResearchPostdoctoral Fellow2008 — 2013
- Wake Forest UniversityGraduate Student2004 — 2008Winston-Salem, NC
- University of PittsburghUndergraduate Researcher2000 — 2003
Skills & more
Cell Biology14Molecular Biology21Microscopy3Immunofluorescence4Molecular Cloning7Western Blotting6In Vivo11Oncology8Signal Transduction2Microbiology2
From Jill's professional profile.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Frequently asked questions
- Who is Jill Wykosky?
- Jill Wykosky is a Venture Partner at Raven (RA Ventures). She previously spent eleven years at Takeda Pharmaceuticals, where she served as Head of Neurogastroenterology Research and built a biology and pharmacology team within the Gastroenterology Drug Discovery Unit, overseeing preclinical discovery work across sites in San Diego, CA and Cambridge, MA. Her drug discovery experience spans small molecule, peptide, antibody, and cell therapy modalities, and she holds a B.S. in Microbiology from the University of Pittsburgh and a Ph.D. in Molecular Medicine from Wake Forest University School of Medicine, followed by a post-doctoral fellowship at the Ludwig Institute for Cancer Research San Diego Branch.
- Where does Jill Wykosky work?
- Jill Wykosky is Venture Partner at RA Capital.
- Where did Jill Wykosky go to school?
- Jill Wykosky studied at Wake Forest University (Ph.D., Molecular Medicine/Cancer Biology); University of Pittsburgh (B.S., Microbiology).
Same school
Also attended Wake Forest University164
Daniel van der MerweSenior Director at JMI EquityNash Carey-EwendSenior Associate, Echo Health Advisors at Echo Health VenturesAndrew McGuirkVenture Fellow at Moneta VenturesEliza CushmanPartner at Congruent VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcJeff BaldwinPrincipal at TCV
+ 158 more
Also attended University of Pittsburgh181
Yervand SarkisyanInvestor in deep tech and AIJon KaplanExecutive Venture Partner at Caduceus Capital PartnersSalvador GalaCo-founder & Managing Partner at Ev3 Ventures LlcJustin MaresBuilding companies at the intersection of health and technology.Kelly BarnumDirector Of Talent at Volition CapitalMatt GurinDirector, Finance and Operations at RRE Ventures
+ 175 more
Shared employers
Also worked at Takeda77
Rebecca RedfieldSenior Associate at .406 VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersDai HataAssociate at AN Venture PartnersJulie KimRepresentative Director – President and CEO at Takeda VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAsuka MiyabashiraPresident, Japan Pharma Business Unit at Takeda Ventures
+ 71 more
Also worked at Ludwig Institute for Cancer Research9
Karen KnudsenAdvisor at Oncology VenturesVincent BrichardVenture Partner at EQT Life SciencesYann EchelardPartner, PhD at ORI CapitalAmel TounsiInvestment Manager at Meusinvest (Noshaq)Khatereh AhmadiVenture Partner at XGEN VentureLeonardo TeixeiraFounder at Endpoint Health
+ 3 more
Also worked at Wake Forest University12
Casey TierneyInvestor at LegalTechJake MorossPrincipal at Torch CapitalRónán CarrVice President, Investments at Greybull Stewardship LLCSophia DoddInvestor at Equal VenturesJessica FreyerPartner at Rhapsody Venture PartnersHemanta BaruahFounder / EIR at 82VS
+ 6 more
Also worked at University of Pittsburgh77
Matt GurinDirector, Finance and Operations at RRE VenturesRyan FrisbiePartner at VIEWPOINT VENTURESVibhu MittalGen AI at SenseAI VenturesStacie McCarthyExecutive Assistant at Standard CryptoJason RobinsSpecial Advisor at Data Point CapitalAshok SrinivasanChief Science Advisor at AIF
+ 71 more